Physician profile
Patrick Tenbrink
NPI 1245685908
$6,471.59
in general payments reported to CMS, 2019-2025
32 companies · $929 in 2025
The $929 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $875 · 2022: $1,533 · 2023: $2,544 · 2024: $591 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,020 · Travel and Lodging: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,019.60 |
| Travel and Lodging | $1,043.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,828.32 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Angiodynamics, INC. | $857.73 | 2022-2024 | Nanoknife |
| Boston Scientific Corporation | $670.73 | 2021-2025 | Ams 700, Rezum Generator, Axonics |
| Coloplast Corp | $412.04 | 2021-2025 | Self-Cath, Speedicath |
| Medtronic, INC. | $358.28 | 2021-2025 | Altaviva, Interstim |
| Astellas Pharma US INC | $262.51 | 2021-2024 | Xtandi, Myrbetriq |
| Ferring Pharmaceuticals INC. | $261.90 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $229.26 | 2021-2023 | Erleada |
| Antares Pharma, INC. | $157.34 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $153.22 | 2022-2024 | Xiaflex, Aveed, Edex |
| Laborie Medical Technologies Corp. | $133.00 | 2023-2025 | |
| Urogen Pharma, INC. | $125.96 | 2022-2025 | Jelmyto |
| Abbvie INC. | $120.83 | 2021-2024 | Botox |
| Teleflex LLC | $111.45 | 2021-2024 | Urolift |
| Axonics, INC. | $107.75 | 2022-2024 | Axonics |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $103.41 | 2021 | |
| Tolmar, INC. | $88.75 | 2023-2025 | Jatenzo, Eligard |
| Agiliti Surgical, INC. | $68.92 | 2025 | Sonablate Hifu |
| C. R. Bard, INC. & Subsidiaries | $61.40 | 2025 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $55.91 | 2023-2024 | Orgovyx |
| Tolmar Pharmaceuticals, INC. | $38.63 | 2021-2022 | |
| Halozyme INC | $38.23 | 2023 | |
| Heron Therapeutics, INC. | $36.63 | 2025 | Zynrelef |
| Blue Earth Diagnostics | $29.14 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.09 | 2023 | |
| Olympus America INC. | $21.53 | 2023 | Itind System |
| Pfizer INC. | $21.53 | 2022 | |
| Myriad Genetic Laboratories, INC. | $21.04 | 2023 | Prolaris |
| Immunitybio, INC. | $20.36 | 2024 | |
| Endo USA, INC. | $18.51 | 2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $17.76 | 2022 | |
| Karl Storz Endoscopy-America | $15.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Tenbrink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.